Top 5 News Articles in 2023
News about state bans on accumulators, Pfizer’s announcements about vaccines and cardiovascular deaths increasing because of climate change were the most viewed news items on the Managed Healthcare Executive website this year.
Here are the top five news articles published on the Managed Healthcare Executive website this year.\
States Are Moving to Ban Accumulators
Sixteen states have banned a pharmacy benefit management practice that involves not counting the value of drug copay assistance from manufacturers toward patient deductibles.
Vaccine Updates: Two Announcements From Pfizer
Pfizer and BioNTech released positive top-line data for their mRNA-based combination vaccine that targets influenza and COVID-19.
Study Predicts Alarming Increase in Cardiovascular Deaths Due to Impact of Extreme Heat
Recent data found that extreme heat is projected to lead to a significantly higher burden of excess cardiovascular deaths in the United States by midcentury (2036–2065), with elderly adults and non-Hispanic Black adults being most affected.
New Diabetes Therapeutic Will Sell for $750 for 90 Days, Company Says
However, patients who cannot get insurance coverage will be able to access AspyreRx at a significant self-pay discount.
UnitedHealthcare Removes Out-of-Pocket Costs for Eligible Members Using 24/7 Virtual Visits
Removing out-of-pocket expenses for virtual visits may help improve health equity by reducing medical costs for consumers and encourage earlier interventions.
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Phase 3 Trial of Vertex’s Islet Cell Therapy for Type 1 Diabetes Under Way
April 23rd 2025Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if approved, would be the second cell therapy for type 1 diabetes.
Read More
